Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study)

Background: In patients with congestive heart failure (CHF), clinical trials have demonstrated the benefit of a number of drugs on morbidity and mortality. Nevertheless so far, there is no published controlled study of long‐term antithrombotic therapy in patients with CHF. The aim of this work was t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of heart failure 2002-10, Vol.4 (5), p.647-654
Hauptverfasser:	Echemann, M., Alla, F., Briançon, S., Juillière, Y., Virion, J.M., Mertès, P.M., Villemot, J.P., Zannad, F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Adult Aged Aged, 80 and over Angiotensin-Converting Enzyme Inhibitors - therapeutic use Anticoagulants - therapeutic use antithrombotic treatment Aspirin - therapeutic use Controlled Clinical Trials as Topic Databases, Factual Dose-Response Relationship, Drug epidemiology Female Fibrinolytic Agents - therapeutic use Follow-Up Studies France - epidemiology Heart Failure - drug therapy Heart Failure - mortality Heart Failure - physiopathology Humans Hypolipidemic Agents - therapeutic use Male Middle Aged Prospective Studies severe heart failure Severity of Illness Index survival Survival Analysis Systole - drug effects Systole - physiology Treatment Outcome Ventricular Dysfunction, Left - drug therapy Ventricular Dysfunction, Left - mortality Ventricular Dysfunction, Left - physiopathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!